Table 2: Measures of agreement for each acute serious outcome between the EHR (MedicineInsight) algorithms and linked (Reference) data.
| Study population N=274,420 | Acute Pancreatitis | Myocardial Infarction | Stroke | Suicide | VTE* |
| Reference+ HER+ (True positive) | 79 | 773 | 655 | 177 | 486 |
| Reference- HER+ (False positive) | 26 | 430 | 739 | 406 | 904 |
| Reference+ EHR- (False negative) | 471 | 2,405 | 1,704 | 1,189 | 468 |
| Reference- EHR- (True negative) | 273,844 | 270,812 | 271,322 | 272,648 | 272,562 |
| Sensitivity (95 % CI) | 14.4 (10.5, 18.2) | 24.3 (22.0, 26.7) | 27.8 (25.6, 30.0) | 13.0 (9.8, 16.2) | 50.9 (47.0, 55.0) |
| Specificity (95 % CI) | 100.0 (100.0, 100.0) | 99.8 (99.8, 99.9) | 99.7 (99.7, 99.8) | 99.9 (99.8, 99.9) | 99.7 (99.6, 99.7) |
| PPV (95 %CI) | 75.2 (67.3, 83.1) | 64.3 (59.8, 68.7) | 47.0 (43.2, 50.8) | 30.4 (27.3, 33.4) | 35.0 (31.4, 38.5) |
| NPV (95 % CI) | 99.8 (99.8, 99.9) | 99.1 (90.0, 99.3) | 99.4 (99.3, 99.5) | 99.6 (99.5, 99.6) | 99.8 (99.8, 99.9) |
| PoA (%) | 99.8 | 99.0 | 99.1 | 99.4 | 99.5 |
*Venous Thromboembolism.